logo
[breadcrumb_custom]

Tag: NYSE:EW

CROX
Industry

EW’s Stock Market Pendulum: Swinging Between Gains and Losses

A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The metric has seen a significant gain of 23.69% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 29.30%. Over the past 30 days, the price of EW has fallen by 9.54%. And in the last five days, it has surged by 3.74%. The market performance of Edwards Lifesciences Corp has been somewhat stable. Over the past year, the company’s

TOST Stock
Finance

Edwards Lifesciences Corp (EW) Stock: 52-Week Performance Insights and Trading Volume

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Edwards Lifesciences Corp’s current trading price is -2.39% away from its 52-week high, while its distance from the 52-week low is 52.88%. The stock’s price range for this period has been between $60.57 and $94.87 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.64 million for the day, a number notably lower than the average daily volume of 4.25 million over the last three months. In terms of market performance, Edwards Lifesciences

TOST Stock
Finance

EW’s Stock Market Adventure: 14.12% YTD Growth Amidst Volatility

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The metric has seen a significant gain of 14.12% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 13.80%. Over the past 30 days, the price of EW has fallen by 10.56%. And in the last five days, it has surged by 1.01%. Edwards Lifesciences Corp saw a rather consistency, in terms of market performance. The company’s stock reached its highest

OPEN Stock
Industry

Edwards Lifesciences Corp (EW) Stock: The Story of a 52-Week Stock Range

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Edwards Lifesciences Corp’s current trading price is -9.19% away from its 52-week high, while its distance from the 52-week low is 42.23%. The stock’s price range during this period has varied between $60.57 and $94.87. The company, active in the Healthcare sector, saw a trading volume of around 6.37 million for the day, considerably higher average daily volume of 4.33 million observed over the last three months. Edwards Lifesciences Corp had a pretty favorable run

Industry

Analyzing the Impact of Earnings Reports on Edwards Lifesciences Corp Inc. (EW) Price Performance

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant gain of 12.55% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 7.46%. Over the past 30 days, the price of EW has fallen by 15.99%. And in the last five days, it has fallen by -0.91%. In terms of market performance, Edwards Lifesciences Corp had a somewhat regular. The highest value for the stock in

ELVT Stock
News

Edwards Lifesciences Corp (EW) Stock: Exploring a Year of Highs, Lows, and Trading Volume

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Edwards Lifesciences Corp’s current trading price is -9.25% away from its 52-week high, while its distance from the 52-week low is 42.13%. The stock’s price range during this period has varied between $60.57 and $94.87. The company, active in the Healthcare sector, saw a trading volume of around 11.73 million for the day, considerably higher average daily volume of 4.22 million observed over the last three months. Edwards Lifesciences Corp’s stock market performance has been

SLGG
Stock

A Closer Look at Edwards Lifesciences Corp (EW) Stock Gains

Edwards Lifesciences Corp experienced a rather steady stock market performance. The highest value in the past year was recorded at $94.87 on 06/30/23 and the lowest value was $60.57 on 10/30/23. 52-week price history of EW Stock Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Edwards Lifesciences Corp’s current trading price is -17.22% away from its 52-week high, while its distance from the 52-week low is 29.65%. The stock’s price range during the 52-week period has remained between $60.57 and $94.87. In the Healthcare sector,

Stock

Edwards Lifesciences Corp’s Shares Reel: 5.05% Quarterly Revenue Decline Amid 44.00B Market Cap

The market performance of Edwards Lifesciences Corp’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $94.87 on 06/30/23, while the lowest value for the same duration was $60.57 on 10/30/23. 52-week price history of EW Stock Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Edwards Lifesciences Corp’s current trading price is -23.54% away from its 52-week high, while its distance from the 52-week low is 19.76%. The stock’s price range during the 52-week period

Industry

Edwards Lifesciences Corp (EW) Stock: A Year of Stock Market Ups and Downs

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Edwards Lifesciences Corp’s current trading price is -21.53% away from its 52-week high, while its distance from the 52-week low is 22.90%. The stock’s price range for this time frame has been between $60.57 and $94.87. The trading volume of the company’s shares in the Healthcare reached around 3.8 million for the day, which was evidently lower than the average daily volume of 4.54 million over the last three months. In terms of market performance, Edwards Lifesciences Corp had